Koppers Holdings Inc.

DB:KO9 Stock Report

Market Cap: €734.6m

Koppers Holdings Valuation

Is KO9 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of KO9 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: KO9 (€36.4) is trading above our estimate of fair value (€5.93)

Significantly Below Fair Value: KO9 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for KO9?

Key metric: As KO9 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for KO9. This is calculated by dividing KO9's market cap by their current earnings.
What is KO9's PE Ratio?
PE Ratio10.3x
EarningsUS$75.50m
Market CapUS$776.10m

Price to Earnings Ratio vs Peers

How does KO9's PE Ratio compare to its peers?

The above table shows the PE ratio for KO9 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average13x
SIM0 SIMONA
11.1xn/a€342.0m
FPE3 Fuchs
18.7x8.7%€4.9b
ACT AlzChem Group
11.6x12.6%€582.1m
STO3 Sto SE KGaA
10.6x3.5%€700.4m
KO9 Koppers Holdings
10.3x19.4%€776.1m

Price-To-Earnings vs Peers: KO9 is good value based on its Price-To-Earnings Ratio (10.3x) compared to the peer average (13.2x).

Price to Earnings Ratio vs Industry

How does KO9's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
KO9 10.3xIndustry Avg. 17.3xNo. of Companies12PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: KO9 is good value based on its Price-To-Earnings Ratio (10.3x) compared to the European Chemicals industry average (17.2x).

Price to Earnings Ratio vs Fair Ratio

What is KO9's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

KO9 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio10.3x
Fair PE Ratio15.5x

Price-To-Earnings vs Fair Ratio: KO9 is good value based on its Price-To-Earnings Ratio (10.3x) compared to the estimated Fair Price-To-Earnings Ratio (15.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst KO9 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€36.40
€60.75
+66.9%
0.8%€61.22€60.28n/a2
Nov ’25€31.00
€59.01
+90.4%
0.8%€59.47€58.55n/a2
Oct ’25€32.60
€59.01
+81.0%
0.8%€59.47€58.55n/a2
Sep ’25€35.00
€59.01
+68.6%
0.8%€59.47€58.55n/a2
Aug ’25€37.40
€59.39
+58.8%
0.8%€59.85€58.92n/a2
Jul ’25€34.20
€59.39
+73.6%
0.8%€59.85€58.92n/a2
Jun ’25€40.40
€59.39
+47.0%
0.8%€59.85€58.92n/a2
May ’25€49.40
€59.68
+20.8%
0.8%€60.14€59.21n/a2
Apr ’25€50.50
€59.68
+18.2%
0.8%€60.14€59.21n/a2
Mar ’25€52.00
€59.68
+14.8%
0.8%€60.14€59.21n/a2
Feb ’25€47.20
€59.27
+25.6%
0.8%€59.73€58.81n/a2
Jan ’25€46.60
€44.41
-4.7%
5.3%€46.75€42.08n/a2
Dec ’24€41.20
€44.41
+7.8%
5.3%€46.75€42.08n/a2
Nov ’24€34.20
€44.56
+30.3%
5.3%€46.90€42.21€31.002
Oct ’24€37.80
€44.56
+17.9%
5.3%€46.90€42.21€32.602
Sep ’24€35.20
€43.39
+23.3%
5.3%€45.68€41.11€35.002
Aug ’24€34.60
€37.44
+8.2%
15.0%€44.93€31.45€37.403
Jul ’24€30.80
€39.07
+26.9%
13.2%€45.97€32.18€34.204
Jun ’24€27.00
€39.07
+44.7%
13.2%€45.97€32.18€40.404
May ’24€29.20
€39.86
+36.5%
13.2%€46.90€32.83€49.404
Apr ’24€30.80
€39.86
+29.4%
13.2%€46.90€32.83€50.504
Mar ’24€33.60
€39.86
+18.6%
13.2%€46.90€32.83€52.004
Feb ’24€31.60
€39.73
+25.7%
19.5%€49.06€28.45€47.204
Jan ’24€26.60
€39.73
+49.4%
19.5%€49.06€28.45€46.604
Dec ’23€28.40
€39.73
+39.9%
19.5%€49.06€28.45€41.204
Nov ’23€25.20
€39.32
+56.0%
23.8%€49.78€24.89€34.204

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

Central Asia Metals

UK£283.6m

Operates as a base metals producer.

9C3

UK£1.91

7D

2.7%

1Y

2.1%

Cabka

€62.8m

Manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally.

7GW

€2.48

7D

0%

1Y

-59.9%

African Rainbow Minerals

R31.4b

Through its subsidiaries, operates as a diversified mining and minerals company in South Africa, Malaysia, and Switzerland.

EB9

R8.30

7D

-1.2%

1Y

-6.2%